MaggieC.(Eidson)FaderMD

Pediatric Hematology & Oncology • Miami, FL

Physician

Join to view full profile

Dr. Fader is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Fader's full profile

Already have an account?

Office
3100 SW 62 Avenue -NE Wing #121
#121
Miami, FL 33155
Phone+1 305-662-8360

Fax+1 305-666-6387
Is this information wrong?

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2006 - 2009
University of Miami/Jackson Health SystemResidency, Pediatrics, 2002 - 2005
University of Miami Leonard M. Miller School of MedicineClass of 2002

Certifications & Licensure

FL State Medical License 2005 - 2026
NY State Medical License 2005 - 2011
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancers.
Arlet M Acanda De La Rocha, Noah E Berlow, Maggie Fader, Ebony R Coats, Cima Saghira, Paula S Espinal, Jeanette Galano, Ziad Khatib, Haneen Abdella, Ossama M Maher, Ya...> ;Nature Medicine. 2024 Apr 11
An Oncoplastic Approach to Primary Pediatric Pterygomaxillary Osteosarcoma.
Ashley L Ramirez, Alexandra N Townsend, Lee Weber, Pedro S Piccinini, Erin M Wolfe, Marek W Taylor, Thomas A Haglund, Muhanad A Shraiteh, Robert Hannan, Maggie E Fader...> ;The Cleft Palate-Craniofacial Journal. 2023 Mar 27
FANCC and PTCH1 gene loss in congenital infantile rhabdomyosarcoma with spindle cell features.
Kei Shing Oh, Ferial Alloush, Maggie Fader, Carole Brathwaite> ;Pediatric Blood & Cancer. 2023 Apr 1
2 citations
Clinical Utility of Functional Precision Medicine in the Management of Recurrent/Relapsed Childhood Rhabdomyosarcoma
Arlet M. Acanda de la Rocha, Maggie Fader, Ebony R Coats, Paula S Espinal, Vanessa Berrios, Cima Saghira, Ileana Sotto, Rojesh Shakya, Michelin Janvier, Ziad Khatib, H...> ;JCO Precision Oncology. 2021 Oct 27
Altered development of NKT cells, gammadelta T cells, CD8 T cells and NK cells in a PLZF deficient patient.
Eidson M, Wahlstrom J, Beaulieu AM, Zaidi B, Carsons SE, Crow PK, Yuan J, Wolchok JD, Horsthemke B, Wieczorek D, Sant'Angelo DB> ;PLoS One. 2011
PLZF induces the spontaneous acquisition of memory/effector functions in T cells independently of NKT cell-related signals.
Kovalovsky D, Alonzo ES, Uche OU, Eidson M, Nichols KE, Sant'Angelo DB> ;J Immunol. 2010 Jun 15
The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions.
Kovalovsky D, Uche OU, Eladad S, Hobbs RM, Yi W, Alonzo E, Chua K, Eidson M, Kim HJ, Im JS, Pandolfi PP, Sant'Angelo DB> ;Nat Immunol. 2008 Sep
Join now to see all

Press Mentions

What Aidan Taught Me and John HopkinsJanuary 8th, 2018
Healthcare Partnership to Advance Pediatric Research and Spur More Positive OutcomesJanuary 9th, 2017
Groundbreaking Treatment Approach Shows Promise in Hard-to-Treat CancersApril 12th, 2024
Join now to see all